CSIMarket
 


Invivo Therapeutics Holdings Corp   (NVIV)
Other Ticker:  
 

Cumulative Invivo Therapeutics Holdings 's Leverage Ratio for Trailing Twelve Months Period

NVIV's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

NVIV Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth -11.67 % -9.65 % -13.15 % -13.08 % -51.8 %
Y / Y Total Liabilities Growth -76.81 % -55.44 % -34.43 % -18.64 % 27.93 %
Leverage Ratio for Trailing Twelve Months Period 0.13 0.17 0.2 0.2 0.21
Total Ranking # 299 # 456 # 547 # 665 # 670
Seq. Equity Growth -22.97 % -14.09 % -14.42 % 55.96 % -21.21 %
Seq. Total Liabilities Growth -48.09 % -26.31 % -35.04 % -6.69 % -0.24 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to debt repayement of -48.09% Invivo Therapeutics Holdings decreased Leverage Ratio for Trailing Twelve Months Period in the III. Quarter to 0.13, below company's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 2 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Invivo Therapeutics Holdings . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are NVIV's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 3
Sector # 56
S&P 500 # 110


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
1.27 0.36 0.12
(Jun 30 2018)   (Dec 31 2021)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Medical Equipment & Supplies Industry Leverage Ratio for Trailing Twelve Months Period
Penumbra Inc   0.35 
Sight Sciences Inc   0.34 
Pulmonx Corporation  0.34 
Nexalin Technology Inc   0.33 
Angiodynamics Inc   0.32 
Glucotrack Inc   0.31 
Koru Medical Systems Inc  0.31 
Lyra Therapeutics Inc   0.31 
Vicarious Surgical Inc   0.30 
Neuroone Medical Technologies Corporation  0.30 
West Pharmaceutical Services Inc   0.30 
Ir med Inc   0.29 
Atricure Inc   0.29 
Fonar Corporation  0.29 
Endra Life Sciences Inc   0.29 
Enovis Corporation  0.26 
Predictive Oncology Inc   0.26 
Sharecare Inc   0.24 
Bluejay Diagnostics Inc   0.24 
Staar Surgical Company  0.24 
Nutriband Inc   0.24 
Bone Biologics Corporation  0.24 
Sharps Technology Inc   0.23 
Asensus Surgical Inc   0.23 
Biolife Solutions Inc   0.22 
Akili Inc   0.22 
Microbot Medical Inc   0.21 
Cardiovascular Systems Inc   0.21 
Inari Medical Inc   0.20 
Aethlon Medical Inc   0.20 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com